Company intelligence / Profile preview
NOxy Health Products
- Ownership
- Private
- Employees
- ~3
- Development stage
- Preclinical
Overview
NOxy Health Products has developed a novel nitric oxide-releasing foam designed to address limitations of current nitric oxide delivery systems for chronic wound care. The company’s lead program is entering first-in-human trials and aims to demonstrate safety and efficacy in chronic wound healing. Early non-clinical data support the platform’s potential as a breakthrough solution
- Therapeutic areas
- OtherEndocrinologyDermatology
- Modalities
- Small molecule (nitric oxide-based)Device (NO-releasing foam technology)
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on NOxy Health Products.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NOxy Health Products.